Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
McMurry-Heath MichelleDirector | BioventusBVS | Open-market sale | 03/11 | 03/13 | 12,000 sh | $8.79 | $105,480 | −21.1% |
Guy P. NohraDirector | BioventusBVS | Open-market sale | 25/12/04 | 25/12/08 | 10,000 sh | $7.57 | $75,700 | −7.9% |
McMurry-Heath MichelleDirector | BioventusBVS | Open-market sale | 25/11/07 | 25/11/10 | 17,701 sh | $7.42 | $131,341.42 | −23.7% |
Katrina J. ChurchSVP & Chief Compliance Officer | BioventusBVS | Open-market sale10b5-1 plan | 25/04/11 | 25/04/15 | 1,283 sh | $7.57 | $9,712.31 | −2.3% |
Anthony D'AdamioSVP & General Counsel | BioventusBVS | Open-market sale10b5-1 plan | 25/04/11 | 25/04/15 | 2,958 sh | $7.57 | $22,392.06 | −2.2% |
Mark Leonard SingletonSVP & CFO | BioventusBVS | Open-market sale10b5-1 plan | 25/04/11 | 25/04/15 | 3,875 sh | $7.57 | $29,333.75 | −2.7% |
Mark Leonard SingletonSVP & CFO | BioventusBVS | Open-market sale10b5-1 plan | 25/03/24 | 25/03/25 | 5,479 sh | $9.79 | $53,639.41 | −4.0% |
Katrina J. ChurchSVP & Chief Compliance Officer | BioventusBVS | Open-market sale10b5-1 plan | 25/03/17 | 25/03/18 | 1,018 sh | $9.75 | $9,925.5 | −1.9% |
Anthony D'AdamioSVP & General Counsel | BioventusBVS | Open-market sale10b5-1 plan | 25/03/17 | 25/03/18 | 2,615 sh | $9.75 | $25,496.25 | −2.1% |
Katrina J. ChurchSVP & Chief Compliance Officer | BioventusBVS | Open-market sale10b5-1 plan | 25/02/18 | 25/02/20 | 1,537 sh | $10.19 | $15,662.03 | −3.0% |
Anthony D'AdamioSVP & General Counsel | BioventusBVS | Open-market sale10b5-1 plan | 25/02/18 | 25/02/20 | 4,380 sh | $10.19 | $44,632.2 | −3.6% |
Mark Leonard SingletonSVP & CFO | BioventusBVS | Open-market sale10b5-1 plan | 25/02/18 | 25/02/20 | 6,498 sh | $10.19 | $66,214.62 | −5.2% |
Claypoole Robert E.President and CEO | BioventusBVS | Open-market sale10b5-1 plan | 25/01/13 | 25/01/14 | 28,786 sh | $9.10 | $261,952.6 | −30.7% |
Katrina J. ChurchSVP & Chief Compliance Officer | BioventusBVS | Open-market sale10b5-1 plan | 24/12/23 | 24/12/26 | 2,535 sh | $10.53 | $26,693.55 | −5.1% |
Anthony D'AdamioSVP & General Counsel | BioventusBVS | Open-market sale10b5-1 plan | 24/12/23 | 24/12/26 | 5,848 sh | $10.53 | $61,579.44 | −5.1% |
Mark Leonard SingletonSVP & CFO | BioventusBVS | Open-market sale10b5-1 plan | 24/12/23 | 24/12/26 | 10,733 sh | $10.53 | $113,018.49 | −9.3% |
BioventusBVS | Open-market buy | 24/08/16–24/08/19 | 24/08/20 | 105,500 sh2 trades | $8.55avg. | $902,025 | +1.5% | |
Katrina J. ChurchSVP & Chief Compliance Officer | BioventusBVS | Open-market sale10b5-1 plan | 24/06/21 | 24/06/25 | 2,559 sh | $5.57 | $14,253.63 | −5.8% |
Anthony D'AdamioSVP & General Counsel | BioventusBVS | Open-market sale10b5-1 plan | 24/06/21 | 24/06/25 | 5,904 sh | $5.57 | $32,885.28 | −5.8% |
Mark Leonard SingletonSVP & CFO | BioventusBVS | Open-market sale10b5-1 plan | 24/06/21 | 24/06/25 | 9,219 sh | $5.57 | $51,349.83 | −9.8% |